Does EPLERENONE Cause Obesity? 29 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 29 reports of Obesity have been filed in association with EPLERENONE (Inspra). This represents 0.8% of all adverse event reports for EPLERENONE.
29
Reports of Obesity with EPLERENONE
0.8%
of all EPLERENONE reports
0
Deaths
9
Hospitalizations
How Dangerous Is Obesity From EPLERENONE?
Of the 29 reports, 9 (31.0%) required hospitalization.
Is Obesity Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EPLERENONE. However, 29 reports have been filed with the FAERS database.
What Other Side Effects Does EPLERENONE Cause?
Acute kidney injury (570)
Hypotension (398)
Dyspnoea (395)
Cardiac failure (338)
Oedema peripheral (268)
Dizziness (248)
Hyperkalaemia (248)
Drug ineffective (244)
Fatigue (202)
Off label use (188)
What Other Drugs Cause Obesity?
RISPERIDONE (3,039)
PREDNISONE (1,880)
METHOTREXATE (1,876)
ADALIMUMAB (1,780)
TOCILIZUMAB (1,630)
ABATACEPT (1,605)
INFLIXIMAB (1,536)
HYDROXYCHLOROQUINE (1,532)
SULFASALAZINE (1,455)
ETANERCEPT (1,407)
Which EPLERENONE Alternatives Have Lower Obesity Risk?
EPLERENONE vs EPLONTERSEN
EPLERENONE vs EPOETIN ALFA-EPBX
EPLERENONE vs EPOGEN
EPLERENONE vs EPOPROSTENOL
EPLERENONE vs EPTIFIBATIDE